Pasithea Therapeutics Corp. (KTTA:NASDAQ) closed at $0.410 on October 15, 2026, up 0.17% on the day. The stock trades 80.1% below its 52-week high of $2.06 and 45.9% above its 52-week low of $0.281. Over the past year, it lost 43.4%. Pasithea Therapeutics Corp. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -8.51% | -18.12% | -9.02% | -42.90% | -43.37% |
In 252 trading sessions since October 14, 2025, KTTA closed higher on 103 days (41%). Its best day was November 26, 2025 (+117.21%) and its worst was November 21, 2025 (-29.64%). The stock moved 10% or more in a single session 17 times. It opened at least 5% above the previous day's high 2 times.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.
Find more stocks like KTTA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.